925 related articles for article (PubMed ID: 31691256)
1. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Patek TM; Teng C; Kennedy KE; Alvarez CA; Frei CR
Drug Saf; 2020 Jan; 43(1):17-22. PubMed ID: 31691256
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Teng C; Baus C; Wilson JP; Frei CR
Int J Med Sci; 2019; 16(11):1504-1509. PubMed ID: 31673242
[No Abstract] [Full Text] [Related]
3. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
4. Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
Teng C; Walter EA; Gaspar DKS; Obodozie-Ofoegbu OO; Frei CR
Int J Med Sci; 2019; 16(7):1018-1022. PubMed ID: 31341415
[No Abstract] [Full Text] [Related]
5.
Teng C; Reveles KR; Obodozie-Ofoegbu OO; Frei CR
Int J Med Sci; 2019; 16(5):630-635. PubMed ID: 31217729
[No Abstract] [Full Text] [Related]
6. Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.
Fan Q; Ma J; Zhang B; Li Q; Liu F; Zhao B
Cancer Chemother Pharmacol; 2020 Nov; 86(5):655-662. PubMed ID: 33001273
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial-associated acute kidney injury among older adults: A post-marketing surveillance study using the FDA adverse events reporting system.
Chinzowu T; Chyou TY; Nishtala PS
Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1190-1198. PubMed ID: 35670078
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).
Kennedy KE; Teng C; Patek TM; Frei CR
Drug Saf; 2020 Apr; 43(4):363-369. PubMed ID: 31863282
[TBL] [Abstract][Full Text] [Related]
10. Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Teng C; Frei CR
Drugs Real World Outcomes; 2022 Mar; 9(1):23-29. PubMed ID: 34275113
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS).
Truong CB; Durham SH; Qian J
Expert Opin Drug Saf; 2021 May; 20(5):603-609. PubMed ID: 33573405
[No Abstract] [Full Text] [Related]
12. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
Wu B; Li D; Xu T; Luo M; He Z; Li Y
Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
[TBL] [Abstract][Full Text] [Related]
13. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.
Orogun L; Chyou TY; Nishtala PS
Int J Risk Saf Med; 2023; 34(2):87-99. PubMed ID: 37154187
[TBL] [Abstract][Full Text] [Related]
14. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
Wei C; Liu Y; Jiang A; Wu B
Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study.
Zhu J; Wu J; Chen P; You K; Su J; Gao Z; Bi Z; Feng M
Int Immunopharmacol; 2022 Dec; 113(Pt A):109350. PubMed ID: 36272360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database.
Nakao S; Hasegawa S; Umetsu R; Shimada K; Mukai R; Tanaka M; Matsumoto K; Yoshida Y; Inoue M; Satake R; Nishibata Y; Liao J; Nakamura M
BMC Pharmacol Toxicol; 2021 Aug; 22(1):47. PubMed ID: 34462002
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database.
Uchida M; Kondo Y; Suzuki S; Hosohata K
Ann Pharmacother; 2019 Dec; 53(12):1200-1206. PubMed ID: 31347378
[No Abstract] [Full Text] [Related]
18. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System.
Yue Z; Shi J; Li H; Li H
Biol Pharm Bull; 2018 Feb; 41(2):158-162. PubMed ID: 29187701
[TBL] [Abstract][Full Text] [Related]
19. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
[TBL] [Abstract][Full Text] [Related]
20. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.
Pierson-Marchandise M; Gras V; Moragny J; Micallef J; Gaboriau L; Picard S; Choukroun G; Masmoudi K; Liabeuf S;
Br J Clin Pharmacol; 2017 Jun; 83(6):1341-1349. PubMed ID: 28002877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
